PubMed

CR represents an early index of potential long survival in multiple myeloma.

Wang M, Delasalle K, Feng L, Thomas S, Giralt S, Qazilbash M, Handy B, Lee JJ, Alexanian R.

Bone Marrow Transplant. 2009 Jul 27. [Epub ahead of print]PMID: 19633690 [PubMed - as supplied by publisher]Related articles

Updated survival analyses after prolonged follow-up of the phase 2, multicenter CREST study of bortezomib in relapsed or refractory multiple myeloma.

Jagannath S, Barlogie B, Berenson JR, Siegel DS, Irwin D, Richardson PG, Niesvizky R, Alexanian R, Limentani SA, Alsina M, Esseltine DL, Anderson KC.

Br J Haematol. 2008 Nov;143(4):537-40. Epub 2008 Sep 6.PMID: 18783399 [PubMed - indexed for MEDLINE]Related articles

Current treatment strategies for multiple myeloma.

Thomas S, Alexanian R.

Clin Lymphoma Myeloma. 2007 Apr;7 Suppl 4:S139-44. Review.PMID: 17562251 [PubMed - indexed for MEDLINE]Related articles

Bortezomib in combination with thalidomide-dexamethasone for previously untreated multiple myeloma.

Wang M, Giralt S, Delasalle K, Handy B, Alexanian R.

Hematology. 2007 Jun;12(3):235-9.PMID: 17558699 [PubMed - indexed for MEDLINE]Related articles

Results of a retrospective single institution analysis of targeted skeletal radiotherapy with (166)Holmium-DOTMP as conditioning regimen for autologous stem cell transplant for patients with multiple myeloma. Impact on transplant outcomes.

Christoforidou AV, Saliba RM, Williams P, Qazilbash M, Roden L, Aleman A, Weber D, Mendoza F, Podoloff D, Wendt R 3rd, Breitz H, Alexanian R, Champlin R, Giralt S.

Biol Blood Marrow Transplant. 2007 May;13(5):543-9. Epub 2007 Feb 26.PMID: 17448913 [PubMed - indexed for MEDLINE]Related articles

International uniform response criteria for multiple myeloma.

Durie BG, Harousseau JL, Miguel JS, Bladé J, Barlogie B, Anderson K, Gertz M, Dimopoulos M, Westin J, Sonneveld P, Ludwig H, Gahrton G, Beksac M, Crowley J, Belch A, Boccadaro M, Cavo M, Turesson I, Joshua D, Vesole D, Kyle R, Alexanian R, Tricot G, Attal M, Merlini G, Powles R, Richardson P, Shimizu K, Tosi P, Morgan G, Rajkumar SV; International Myeloma Working Group.

Leukemia. 2006 Sep;20(9):1467-73. Epub 2006 Jul 20. Erratum in: Leukemia. 2006 Dec;20(12):2220. Leukemia. 2007 May;21(5):1134. PMID: 16855634 [PubMed - indexed for MEDLINE]Related articles

Frequency, characteristics, and reversibility of peripheral neuropathy during treatment of advanced multiple myeloma with bortezomib.

Richardson PG, Briemberg H, Jagannath S, Wen PY, Barlogie B, Berenson J, Singhal S, Siegel DS, Irwin D, Schuster M, Srkalovic G, Alexanian R, Rajkumar SV, Limentani S, Alsina M, Orlowski RZ, Najarian K, Esseltine D, Anderson KC, Amato AA.

J Clin Oncol. 2006 Jul 1;24(19):3113-20. Epub 2006 Jun 5.PMID: 16754936 [PubMed - indexed for MEDLINE]Related articles

Safety of prolonged therapy with bortezomib in relapsed or refractory multiple myeloma.

Berenson JR, Jagannath S, Barlogie B, Siegel DT, Alexanian R, Richardson PG, Irwin D, Alsina M, Rajkumar SV, Srkalovic G, Singhal S, Limentani S, Niesvizky R, Esseltine DL, Trehu E, Schenkein DP, Anderson K.

Cancer. 2005 Nov 15;104(10):2141-8.PMID: 16206291 [PubMed - indexed for MEDLINE]Related articlesFree article

Prognostic significance of magnetic resonance imaging of bone marrow in previously untreated patients with multiple myeloma.

Moulopoulos LA, Gika D, Anagnostopoulos A, Delasalle K, Weber D, Alexanian R, Dimopoulos MA.

Ann Oncol. 2005 Nov;16(11):1824-8. Epub 2005 Aug 8.PMID: 16087694 [PubMed - indexed for MEDLINE]Related articlesFree article

Thalidomide-dexamethasone as primary therapy for advanced multiple myeloma.

Wang M, Weber DM, Delasalle K, Alexanian R.

Am J Hematol. 2005 Jul;79(3):194-7.PMID: 15981221 [PubMed - indexed for MEDLINE]Related articles

Atiprimod blocks STAT3 phosphorylation and induces apoptosis in multiple myeloma cells.

Amit-Vazina M, Shishodia S, Harris D, Van Q, Wang M, Weber D, Alexanian R, Talpaz M, Aggarwal BB, Estrov Z.

Br J Cancer. 2005 Jul 11;93(1):70-80.PMID: 15970928 [PubMed - indexed for MEDLINE]Related articlesFree article

Bortezomib in recurrent and/or refractory multiple myeloma. Initial clinical experience in patients with impared renal function.

Jagannath S, Barlogie B, Berenson JR, Singhal S, Alexanian R, Srkalovic G, Orlowski RZ, Richardson PG, Anderson J, Nix D, Esseltine DL, Anderson KC; SUMMIT/CREST Investigators.

Cancer. 2005 Mar 15;103(6):1195-200.PMID: 15690325 [PubMed - indexed for MEDLINE]Related articlesFree article

How we treat Waldenström's macroglobulinemia.

Dimopoulos MA, Merlini G, Leblond V, Anagnostopoulos A, Alexanian R.

Haematologica. 2005 Jan;90(1):117-25. Review.PMID: 15642678 [PubMed - indexed for MEDLINE]Related articlesFree article

A phase 2 study of two doses of bortezomib in relapsed or refractory myeloma.

Jagannath S, Barlogie B, Berenson J, Siegel D, Irwin D, Richardson PG, Niesvizky R, Alexanian R, Limentani SA, Alsina M, Adams J, Kauffman M, Esseltine DL, Schenkein DP, Anderson KC.

Br J Haematol. 2004 Oct;127(2):165-72.PMID: 15461622 [PubMed - indexed for MEDLINE]Related articles

Treatment of Waldenstrom's macroglobulinemia with rituximab: prognostic factors for response and progression.

Dimopoulos MA, Alexanian R, Gika D, Anagnostopoulos A, Zervas C, Zomas A, Kyrtsonis MC, Anagnostopoulos N, Pangalis GA, Weber DM.

Leuk Lymphoma. 2004 Oct;45(10):2057-61.PMID: 15370250 [PubMed - indexed for MEDLINE]Related articles

Comparison of high-dose melphalan with a more intensive regimen of thiotepa, busulfan, and cyclophosphamide for patients with multiple myeloma.

Anagnostopoulos A, Aleman A, Ayers G, Donato M, Champlin R, Weber D, Alexanian R, Giralt S.

Cancer. 2004 Jun 15;100(12):2607-12.PMID: 15197803 [PubMed - indexed for MEDLINE]Related articlesFree article

Clinical outcomes with intensive therapy for patients with primary resistant multiple myeloma.

Alexanian R, Weber D, Delasalle K, Handy B, Champlin R, Giralt S.

Bone Marrow Transplant. 2004 Aug;34(3):229-34.PMID: 15170166 [PubMed - indexed for MEDLINE]Related articles

High-dose topotecan, melphalan and cyclophosphamide (TMC) with stem cell support: a new regimen for the treatment of multiple myeloma.

Donato ML, Aleman A, Champlin RE, Weber D, Alexanian R, Ippoliti CM, de Lima M, Anagnostopoulos A, Giralt S.

Leuk Lymphoma. 2004 Apr;45(4):755-9.PMID: 15160952 [PubMed - indexed for MEDLINE]Related articles

Nuclear factor-kappaB and STAT3 are constitutively active in CD138+ cells derived from multiple myeloma patients, and suppression of these transcription factors leads to apoptosis.

Bharti AC, Shishodia S, Reuben JM, Weber D, Alexanian R, Raj-Vadhan S, Estrov Z, Talpaz M, Aggarwal BB.

Blood. 2004 Apr 15;103(8):3175-84. Epub 2003 Dec 18.PMID: 15070700 [PubMed - indexed for MEDLINE]Related articlesFree article

Thalidomide with or without dexamethasone for refractory or relapsing multiple myeloma.

Alexanian R, Weber D, Anagnostopoulos A, Delasalle K, Wang M, Rankin K.

Semin Hematol. 2003 Oct;40(4 Suppl 4):3-7. Review.PMID: 15015890 [PubMed - indexed for MEDLINE]Related articles

Outcomes of autologous stem cell transplantation in patients with multiple myeloma who received dexamethasone-based nonmyelosuppressive induction therapy.

Anagnostopoulos A, Aleman A, Yang Y, Donato M, Weber D, Champlin R, Smith T, Alexanian R, Giralt S.

Bone Marrow Transplant. 2004 Mar;33(6):623-8.PMID: 14730336 [PubMed - indexed for MEDLINE]Related articles

A phase 2 study of bortezomib in relapsed, refractory myeloma.

Richardson PG, Barlogie B, Berenson J, Singhal S, Jagannath S, Irwin D, Rajkumar SV, Srkalovic G, Alsina M, Alexanian R, Siegel D, Orlowski RZ, Kuter D, Limentani SA, Lee S, Hideshima T, Esseltine DL, Kauffman M, Adams J, Schenkein DP, Anderson KC.

N Engl J Med. 2003 Jun 26;348(26):2609-17.PMID: 12826635 [PubMed - indexed for MEDLINE]Related articlesFree article

Thalidomide and dexamethasone for resistant multiple myeloma.

Anagnostopoulos A, Weber D, Rankin K, Delasalle K, Alexanian R.

Br J Haematol. 2003 Jun;121(5):768-71.PMID: 12780791 [PubMed - indexed for MEDLINE]Related articles

166Ho-DOTMP plus melphalan followed by peripheral blood stem cell transplantation in patients with multiple myeloma: results of two phase 1/2 trials.

Giralt S, Bensinger W, Goodman M, Podoloff D, Eary J, Wendt R, Alexanian R, Weber D, Maloney D, Holmberg L, Rajandran J, Breitz H, Ghalie R, Champlin R.

Blood. 2003 Oct 1;102(7):2684-91. Epub 2003 May 1.PMID: 12730103 [PubMed - indexed for MEDLINE]Related articlesFree article

2-Chlorodeoxyadenosine alone and in combination for previously untreated Waldenstrom's macroglobulinemia.

Weber DM, Dimopoulos MA, Delasalle K, Rankin K, Gavino M, Alexanian R.

Semin Oncol. 2003 Apr;30(2):243-7.PMID: 12720145 [PubMed - indexed for MEDLINE]Related articles

Asymptomatic Waldenstrom's macroglobulinemia.

Alexanian R, Weber D, Delasalle K, Cabanillas F, Dimopoulos M.

Semin Oncol. 2003 Apr;30(2):206-10.PMID: 12720137 [PubMed - indexed for MEDLINE]Related articles

Prognostic markers and criteria to initiate therapy in Waldenstrom's macroglobulinemia: consensus panel recommendations from the Second International Workshop on Waldenstrom's Macroglobulinemia.

Kyle RA, Treon SP, Alexanian R, Barlogie B, Björkholm M, Dhodapkar M, Lister TA, Merlini G, Morel P, Stone M, Branagan AR, Leblond V.

Semin Oncol. 2003 Apr;30(2):116-20. Review.PMID: 12720119 [PubMed - indexed for MEDLINE]Related articles

Thalidomide alone or with dexamethasone for previously untreated multiple myeloma.

Weber D, Rankin K, Gavino M, Delasalle K, Alexanian R.

J Clin Oncol. 2003 Jan 1;21(1):16-9.PMID: 12506164 [PubMed - indexed for MEDLINE]Related articles

Fludarabine/melphalan conditioning for allogeneic transplantation in patients with multiple myeloma.

Giralt S, Aleman A, Anagnostopoulos A, Weber D, Khouri I, Anderlini P, Molldrem J, Ueno NT, Donato M, Korbling M, Gajewski J, Alexanian R, Champlin R.

Bone Marrow Transplant. 2002 Sep;30(6):367-73.PMID: 12235521 [PubMed - indexed for MEDLINE]Related articlesFree article

Consolidation therapy of multiple myeloma with thalidomide-dexamethasone after intensive chemotherapy.

Alexanian R, Weber D, Giralt S, Delasalle K.

Ann Oncol. 2002 Jul;13(7):1116-9.PMID: 12176792 [PubMed - indexed for MEDLINE]Related articlesFree article

Persistence of myeloma protein for more than one year after radiotherapy is an adverse prognostic factor in solitary plasmacytoma of bone.

Wilder RB, Ha CS, Cox JD, Weber D, Delasalle K, Alexanian R.

Cancer. 2002 Mar 1;94(5):1532-7.PMID: 11920511 [PubMed - indexed for MEDLINE]Related articlesFree article

Recent advances in treatment of multiple myeloma and Waldenström's macroglobulinemia.

Alexanian R, Weber D.

Biomed Pharmacother. 2001 Nov;55(9-10):550-2. Review. No abstract available. PMID: 11769965 [PubMed - indexed for MEDLINE]Related articles

Cytogenetic findings in lymphoplasmacytic lymphoma/Waldenström macroglobulinemia. Chromosomal abnormalities are associated with the polymorphous subtype and an aggressive clinical course.

Mansoor A, Medeiros LJ, Weber DM, Alexanian R, Hayes K, Jones D, Lai R, Glassman A, Bueso-Ramos CE.

Am J Clin Pathol. 2001 Oct;116(4):543-9.PMID: 11601139 [PubMed - indexed for MEDLINE]Related articlesFree article

Standard-dose therapy for multiple myeloma: The Southwest Oncology Group experience.

Crowley J, Jacobson J, Alexanian R.

Semin Hematol. 2001 Jul;38(3):203-8. Review.PMID: 11486307 [PubMed - indexed for MEDLINE]Related articles

Thiotepa, busulfan, cyclophosphamide (TBC) and autologous hematopoietic transplantation: an intensive regimen for the treatment of multiple myeloma.

Shimoni A, Smith TL, Aleman A, Weber D, Dimopoulos M, Anderlini P, Andersson B, Claxton D, Ueno NT, Khouri I, Donato M, Korbling M, Alexanian R, Champlin R, Giralt S.

Bone Marrow Transplant. 2001 Apr;27(8):821-8.PMID: 11477439 [PubMed - indexed for MEDLINE]Related articlesFree article

Impact of complete remission with intensive therapy in patients with responsive multiple myeloma.

Alexanian R, Weber D, Giralt S, Dimopoulos M, Delasalle K, Smith T, Champlin R.

Bone Marrow Transplant. 2001 May;27(10):1037-43.PMID: 11438818 [PubMed - indexed for MEDLINE]Related articlesFree article

High-dose chemotherapy followed by stem cell transplantation in patients with resistant Waldenstrom's macroglobulinemia.

Anagnostopoulos A, Dimopoulos MA, Aleman A, Weber D, Alexanian R, Champlin R, Giralt S.

Bone Marrow Transplant. 2001 May;27(10):1027-9.PMID: 11438816 [PubMed - indexed for MEDLINE]Related articlesFree article

Imaging of myeloma bone disease--implications for staging, prognosis and follow-up.

Dimopoulos MA, Moulopoulos LA, Datseris I, Weber D, Delasalle K, Gika D, Alexanian R.

Acta Oncol. 2000;39(7):823-7. Review.PMID: 11145440 [PubMed - indexed for MEDLINE]Related articles

Randomized trial of alpha-interferon or dexamethasone as maintenance treatment for multiple myeloma.

Alexanian R, Weber D, Dimopoulos M, Delasalle K, Smith TL.

Am J Hematol. 2000 Nov;65(3):204-9.PMID: 11074536 [PubMed - indexed for MEDLINE]Related articles

Solitary plasmacytoma of bone and asymptomatic multiple myeloma.

Dimopoulos MA, Moulopoulos LA, Maniatis A, Alexanian R.

Blood. 2000 Sep 15;96(6):2037-44. Review.PMID: 10979944 [PubMed - indexed for MEDLINE]Related articlesFree article

Clinical course of solitary extramedullary plasmacytoma.

Liebross RH, Ha CS, Cox JD, Weber D, Delasalle K, Alexanian R.

Radiother Oncol. 1999 Sep;52(3):245-9.PMID: 10580871 [PubMed - indexed for MEDLINE]Related articles

Benzene and multiple myeloma: appraisal of the scientific evidence.

Bergsagel DE, Wong O, Bergsagel PL, Alexanian R, Anderson K, Kyle RA, Raabe GK.

Blood. 1999 Aug 15;94(4):1174-82. Review. No abstract available. PMID: 10438704 [PubMed - indexed for MEDLINE]Related articlesFree article

Differential diagnosis of monoclonal gammopathies.

Alexanian R, Weber D, Liu F.

Arch Pathol Lab Med. 1999 Feb;123(2):108-13. Review.PMID: 10050782 [PubMed - indexed for MEDLINE]Related articles

Guidelines for clinical and laboratory evaluation patients with monoclonal gammopathies.

Keren DF, Alexanian R, Goeken JA, Gorevic PD, Kyle RA, Tomar RH.

Arch Pathol Lab Med. 1999 Feb;123(2):106-7.PMID: 10050781 [PubMed - indexed for MEDLINE]Related articles

Solitary bone plasmacytoma: outcome and prognostic factors following radiotherapy.

Liebross RH, Ha CS, Cox JD, Weber D, Delasalle K, Alexanian R.

Int J Radiat Oncol Biol Phys. 1998 Jul 15;41(5):1063-7.PMID: 9719116 [PubMed - indexed for MEDLINE]Related articles

Long-term follow-up after high-dose therapy for high-risk multiple myeloma.

Barlogie B, Jagannath S, Naucke S, Mattox S, Bracy D, Crowley J, Tricot G, Alexanian R.

Bone Marrow Transplant. 1998 Jun;21(11):1101-7.PMID: 9645572 [PubMed - indexed for MEDLINE]Related articlesFree article

Prognostic value of cytogenetics in multiple myeloma.

Seong C, Delasalle K, Hayes K, Weber D, Dimopoulos M, Swantkowski J, Huh Y, Glassman A, Champlin R, Alexanian R.

Br J Haematol. 1998 Apr;101(1):189-94.PMID: 9576200 [PubMed - indexed for MEDLINE]Related articles

Prognostic features of asymptomatic multiple myeloma.

Weber DM, Dimopoulos MA, Moulopoulos LA, Delasalle KB, Smith T, Alexanian R.

Br J Haematol. 1997 Jun;97(4):810-4.PMID: 9217181 [PubMed - indexed for MEDLINE]Related articles

[Multiple myeloma and chronic lymphocytic leukemia]

Labardini-Méndez J, Alexanian R, Barlogie B.

Rev Invest Clin. 1997 May;49 Suppl 1:28-33. Review. Spanish. No abstract available. PMID: 9380986 [PubMed - indexed for MEDLINE]Related articles

Phase I trial of cyclosporine-induced autologous graft-versus-host disease in patients with multiple myeloma undergoing high-dose chemotherapy with autologous stem-cell rescue.

Giralt S, Weber D, Colome M, Dimopoulos M, Mehra R, Van Besien K, Gajewski J, Andersson B, Khouri I, Przepiorka D, von Wolff B, Delasalle K, Korbling M, Seong D, Alexanian R, Champlin R.

J Clin Oncol. 1997 Feb;15(2):667-73.PMID: 9053492 [PubMed - indexed for MEDLINE]Related articles